Skip to main content
MACROGENICS INC logo

MACROGENICS INC — Investor Relations & Filings

Ticker · MGNX ISIN · US5560991094 LEI · 5493001KJQUA83L8MH79 US Manufacturing
Open in API
Filings indexed 894 across all filing types
Latest filing 2017-05-23 Director's Dealing
Country US United States of America
Listing US MGNX

About MACROGENICS INC

https://www.macrogenics.com/

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-05-23 English
FORM 4
Director's Dealing
2017-05-23 English
FORM 4
Director's Dealing
2017-05-23 English
FORM 4
Director's Dealing
2017-05-23 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 18, 2017, for MacroGenics, Inc. The key content is the submission of matters to a vote of security holders at the 2017 Annual Meeting of Stockholders. It details the voting results for four proposals including election of directors, ratification of auditors, advisory approval of executive compensation, and approval of an employee stock purchase plan. The document is not a full annual report, audit report, or earnings release. It is not a proxy solicitation but reports the official voting results from the shareholder meeting. The document length is 4388 characters, which is relatively short but contains detailed voting results, indicating it is the official declaration of voting results rather than just an announcement or a proxy statement. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2017-05-22 English
SCHEDULE 13G
Major Shareholding Notification
2017-05-08 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.